Armata Pharmaceuticals Inc (ARMP)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $143.94M
Last updated: Nov 17, 2026 at 11:03 AM ET
Armata Pharmaceuticals Inc (ARMP) Earnings: Report Dates and Results
Armata Pharmaceuticals (ARMP) is expected to report earnings on Mar 17, 2027. In the quarter ended Sep 30, 2026, Armata Pharmaceuticals reported EPS of -$0.24, above the -$0.57 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ARMP has an expected report date of Mar 17, 2027.
Earnings History
Of the 39 quarters below that had an estimate, ARMP beat 21, missed 16 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $3.17M, up 173.3% from $1.16M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.24 | -$0.57 | -$0.57 - -$0.54 | +57.89% | Beat | N/A | 2 | 0 up, 2 down | Nov 12, 2026 | $3.17M |
| Jun 30, 2026 | -$0.27 | -$0.48 | -$0.48 - -$0.41 | +43.75% | Beat | N/A | 2 | 0 up, 1 down | Aug 12, 2026 | $2.51M |
| Mar 31, 2026 | -$3.16 | -$0.38 | -$0.38 - -$0.38 | -731.58% | Miss | N/A | 1 | 0 up, 0 down | May 13, 2026 | $789000 |
| Dec 31, 2025 | -$0.51 | -$0.19 | -$0.19 - -$0.19 | -169.05% | Miss | N/A | 1 | 1 up, 0 down | Mar 25, 2026 | $1.08M |
| Sep 30, 2025 | -$0.33 | -$0.42 | -$0.42 - -$0.42 | +21.43% | Beat | N/A | 1 | 1 up, 0 down | Nov 12, 2025 | $1.16M |
| Jun 30, 2025 | -$0.29 | -$0.39 | -$0.39 - -$0.39 | +25.64% | Beat | N/A | 1 | 0 up, 1 down | Aug 12, 2025 | $2.17M |
| Mar 31, 2025 | -$0.20 | -$0.38 | -$0.38 - -$0.38 | +47.37% | Beat | N/A | 1 | 1 up, 0 down | May 14, 2025 | $491000 |
| Dec 31, 2024 | -$0.23 | -$0.35 | -$0.35 - -$0.35 | +33.80% | Beat | N/A | 1 | 1 up, 0 down | Mar 20, 2025 | $1.24M |
| Sep 30, 2024 | -$0.15 | -$0.28 | -$0.28 - -$0.28 | +46.43% | Beat | N/A | 1 | 0 up, 0 down | Nov 13, 2024 | $2.97M |
| Jun 30, 2024 | -$0.40 | -$0.36 | -$0.52 - -$0.36 | -11.11% | Miss | N/A | 2 | 0 up, 0 down | Aug 13, 2024 | N/A |
| Mar 31, 2024 | -$0.33 | -$0.31 | -$0.34 - -$0.28 | -6.45% | Miss | N/A | 2 | 0 up, 0 down | May 7, 2024 | $966000 |
| Dec 31, 2023 | -$0.55 | -$0.35 | -$0.36 - -$0.34 | -57.14% | Miss | N/A | 2 | 0 up, 0 down | Mar 21, 2024 | $1.53M |
| Sep 30, 2023 | -$0.32 | -$0.31 | -$0.33 - -$0.29 | -3.23% | Miss | N/A | 2 | 0 up, 0 down | Nov 14, 2023 | $1.23M |
| Jun 30, 2023 | -$0.27 | -$0.37 | -$0.40 - -$0.35 | +27.03% | Beat | N/A | 2 | 0 up, 0 down | Aug 14, 2023 | $980000 |
| Mar 31, 2023 | -$0.31 | -$0.32 | -$0.35 - -$0.29 | +3.13% | Beat | N/A | 2 | 0 up, 0 down | May 11, 2023 | $796000 |
| Dec 31, 2022 | -$0.29 | -$0.28 | -$0.31 - -$0.25 | -3.57% | Miss | N/A | 2 | 0 up, 0 down | Mar 16, 2023 | $1.05M |
| Sep 30, 2022 | -$0.24 | -$0.28 | -$0.28 - -$0.27 | +14.29% | Beat | N/A | 2 | 0 up, 0 down | Nov 9, 2022 | $1.34M |
| Jun 30, 2022 | -$0.26 | -$0.23 | N/A | -13.04% | Miss | N/A | N/A | 0 up, 0 down | Aug 11, 2022 | $1.88M |
| Mar 31, 2022 | -$0.30 | -$0.21 | -$0.22 - -$0.20 | -42.86% | Miss | N/A | 2 | 0 up, 0 down | May 12, 2022 | $1.24M |
| Dec 31, 2021 | -$0.23 | -$0.28 | -$0.34 - -$0.24 | +17.86% | Beat | N/A | 3 | 0 up, 0 down | Mar 17, 2022 | $989000 |
| Sep 30, 2021 | -$0.25 | -$0.26 | -$0.27 - -$0.25 | +3.85% | Beat | N/A | 3 | 0 up, 0 down | Nov 10, 2021 | $1.25M |
| Jun 30, 2021 | -$0.25 | -$0.26 | -$0.28 - -$0.25 | +3.85% | Beat | N/A | 2 | N/A | Aug 12, 2021 | $1.17M |
| Mar 31, 2021 | -$0.27 | -$0.32 | -$0.36 - -$0.28 | +15.63% | Beat | N/A | 2 | N/A | May 13, 2021 | $1.07M |
| Dec 31, 2020 | -$0.36 | -$0.29 | -$0.32 - -$0.25 | -24.14% | Miss | N/A | 3 | N/A | Mar 18, 2021 | $504000 |
| Sep 30, 2020 | -$0.31 | -$0.25 | -$0.28 - -$0.17 | -24.00% | Miss | N/A | 3 | N/A | Nov 12, 2020 | $288000 |
| Jun 30, 2020 | -$0.26 | -$0.35 | -$0.58 - -$0.18 | +25.71% | Beat | N/A | 3 | N/A | Aug 13, 2020 | $31000 |
| Mar 31, 2020 | -$0.49 | -$0.31 | -$0.35 - -$0.24 | -58.06% | Miss | N/A | 2 | N/A | May 14, 2020 | N/A |
| Dec 31, 2019 | -$0.48 | -$0.72 | -$0.74 - -$0.71 | +33.33% | Beat | N/A | 2 | N/A | Mar 19, 2020 | N/A |
| Sep 30, 2019 | -$0.73 | -$0.45 | -$0.53 - -$0.38 | -62.22% | Miss | N/A | 2 | N/A | Nov 12, 2019 | N/A |
| Jun 30, 2019 | -$0.56 | -$0.36 | -$0.44 - -$0.29 | -55.56% | Miss | N/A | 2 | N/A | Aug 14, 2019 | N/A |
| Mar 31, 2019 | -$1.54 | -$1.54 | N/A | 0.00% | In line | N/A | N/A | N/A | May 6, 2019 | N/A |
| Dec 31, 2018 | -$2.10 | -$0.98 | N/A | -114.29% | Miss | N/A | N/A | N/A | Mar 25, 2019 | N/A |
| Sep 30, 2018 | -$1.40 | -$1.40 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 8, 2018 | N/A |
| Jun 30, 2018 | -$2.66 | -$2.80 | N/A | +5.00% | Beat | N/A | N/A | N/A | Aug 9, 2018 | N/A |
| Mar 31, 2018 | -$3.36 | -$2.66 | N/A | -26.32% | Miss | N/A | N/A | N/A | May 15, 2018 | N/A |
| Dec 31, 2017 | -$3.50 | -$5.04 | N/A | +30.56% | Beat | -933.3% | N/A | N/A | Mar 14, 2018 | $20000 |
| Sep 30, 2017 | -$1.26 | -$6.02 | N/A | +79.07% | Beat | N/A | N/A | N/A | Nov 14, 2017 | $38000 |
| Jun 30, 2017 | -$1.21 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2017 | $28000 |
| Mar 31, 2017 | -$27.16 | -$114.80 | N/A | +76.34% | Beat | N/A | N/A | N/A | May 15, 2017 | $29000 |
| Dec 31, 2016 | $0.42 | -$42.00 | N/A | +101.00% | Beat | N/A | N/A | N/A | Mar 27, 2017 | $22000 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.33, after -$1.11 the year before. It was -$257.18 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.33 | N/A |
| Dec 31, 2024 | -$1.11 | N/A |
| Dec 31, 2023 | -$1.45 | N/A |
| Dec 31, 2022 | -$1.09 | N/A |
| Dec 31, 2021 | -$1.00 | N/A |
| Dec 31, 2020 | -$1.42 | N/A |
| Dec 31, 2019 | -$3.31 | N/A |
| Dec 31, 2018 | -$9.52 | N/A |
| Dec 31, 2017 | -$33.13 | N/A |
| Dec 31, 2016 | -$257.18 | N/A |
Frequently Asked Questions About ARMP
When is Armata Pharmaceuticals's next earnings date?
Armata Pharmaceuticals's next earnings report is expected for Mar 17, 2027.
Did ARMP beat earnings estimates last quarter?
Yes. Armata Pharmaceuticals reported EPS of -$0.24 for the quarter ended Sep 30, 2026, above the -$0.57 estimate, a 57.89% surprise.
What EPS do analysts expect from ARMP next quarter?
The consensus EPS estimate for Armata Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.41 from 4 analysts, with estimates from -$0.56 to -$0.24.
How often does ARMP beat earnings estimates?
Armata Pharmaceuticals beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of -83.84%.
ARMP pages: Overview, Earnings, Forecast, Financials, Competitors